Viyash Scientific Ltd

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. More about the company

₹226
+0.03% today
₹9,975 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dPharmaceuticals 50.4%-2.5 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is VIYASH early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 39
1w13w26w
Week 39 — mature, watch for distribution
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.42x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
MA20 rolling over · -4.7% vs MA50 -4.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-5.4%
3M
-15.9%
6M
+8.5%
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
50.4%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 57 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2026-01-14 → 2026-10-16
S? 39w
2026-01-142026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 39w current
Total tracked: 39 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-16S—
Wk 39 · Vol 0.42x
2026-10-15S—
Wk 39 · Vol 0.22x
2026-10-14S—
Wk 39 · Vol 0.23x
2026-10-13S—
Wk 38 · Vol 0.19x
2026-10-12S—
Wk 38 · Vol 0.26x
2026-10-09S—
Wk 38 · Vol 0.30x
2026-10-08S—
Wk 38 · Vol 0.72x
2026-10-07S—
Wk 38 · Vol 0.58x
2026-10-06S—
Wk 37 · Vol 0.28x
2026-10-05S—
Wk 37 · Vol 0.23x
2026-10-01S—
Wk 37 · Vol 0.68x
2026-09-30S—
Wk 37 · Vol 0.24x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹253
200 DMA
—
52W High
—
52W Low
—
5D Low
₹225.9
Resistance levels (recent highs)
20d High
₹253.8
60d High
₹278.4
120d High
₹294.2
250d High
—
Next resistance
+12.3%
to 20d High
Ask the Market AI about VIYASHAsk →
P/E (TTM)
62.4
Forward 18.8
Earnings Growth (YoY)
+228.4%
Revenue +129.0%
ROE
+11.6%
Profit margin +5.2%
About this companyHealth Care· Pharmaceuticals

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.